The TB-500 fragment retains the critical actin-binding and cell-migration-promoting activities of the full-length TB4 molecule, making it the predominant research form used in pre-clinical peptide studies
Cittadini A, Monti MG, Castiello MC, DArco E, Galasso G, Sorriento D, Saldamarco L, De Paulis A, Napoli R, Iaccarino G: Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury
Understanding these differences helps target copper peptide use for maximum benefit
Patients with copper sensitivity may experience more pronounced injection site reactions, and this is the primary clinical indicator that leads to protocol adjustment or discontinuation
preclinical work also links it to angiogenesis and reduced fibrosis
Insulin growth factor one does many things similar to growth hormone, and it actually is released in response to growth hormone